Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DHSM is $$$$$$$
DHS Holding, Co. (PINKSHEETS: DHSM) has a wholly-owned subsidiary, Lucky Fox Casino, LTD, which operates out of Belize. Lucky Fox Casino, LTD signed a contract with FenServices to have LuckyFoxCasino.com developed and maintained. FenServices licensed software from SoftBet and other vendors that develop online casino gaming software. These vendors are the respective owners of the software that they develop, and through FenServices, Lucky Fox has licensed the use of their software for the LuckyFoxCasino.com website.
DHS Holding, Co. Confirms LuckyFoxCasino.com
DHS Holding, Co. (PINKSHEETS: DHSM) has a wholly-owned subsidiary, Lucky Fox Casino, LTD, which operates out of Belize. Lucky Fox Casino, LTD signed a contract with FenServices to have LuckyFoxCasino.com developed and maintained. FenServices licensed software from SoftBet and other vendors that develop online casino gaming software. These vendors are the respective owners of the software that they develop, and through FenServices, Lucky Fox has licensed the use of their software for the LuckyFoxCasino.com website.
In short, DHS Holding, Co. owns LuckyFoxCasino.com through its subsidiary, Lucky Fox Casino, LTD.
About the company
The primary focus of DHS Holding Co. is directed to pursue mergers and acquisitions of companies with potential for growth and success. DHS is aggressively moving to develop and expand on both domestic and international opportunities that include launching an online casino through Lucky Fox Casino, LTD, a wholly-owned subsidiary of DHS Holding, Co. and SalesKing.com.
Source Information
www.dhsholding.com
www.otcmarkets.com/stock/dhsm/quote
Baristas Files Franchise Documents in 26 Additional States meeting all requirements in over 50% of the nation
SEATTLE, April 16, 2013 /PRNewswire/ -- Baristas Coffee Company Inc. (OTC PINK: BCCI), a fast growing U.S. based beverage and branded products company, today announced that it has filed its Franchise Disclosure Documents with all of the following states: Alabama, Alaska, Arkansas, Colorado, Delaware, Georgia, Idaho, Iowa, Kansas, Louisiana, Massachusetts, Missouri, Mississippi, Montana, Nevada, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Vermont, West Virginia, Washington DC, and Wyoming,
This filing is subsequent to the filing to become registered in Baristas' home state of Washington, as well as additional registration states, New York and California.
Newly appointed Director of Store and Brand Development, Mike Reynolds, stated: "We have now completed the filing process and are now fully compliant to sell franchises in over 50% of the country. We will now roll out our franchising expansion with committed development partners. We will continue to register in other states that we have received strong interest in so that we may also pursue those regions for franchising as well. Baristas offers a very compelling business model and provides the best opportunity in franchising that I have seen in my career and is clearly the best in its sector."
Barry Henthorn CEO commented; "We now can answer the pent up demand for our exciting franchise concept with full confidence that we have met every requirement. This accomplishment has been the result of a committed effort to comply with the differing regulations of multiple states to insure that we comply with all regulations. Franchising is an important aspect of the expansion of the Baristas brand and will also help reduce our cost of goods sold widening our profit margins."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, currently trades under the symbol (OTC PINK: BCCI) has recently made a formal application to the NASDAQ Capital Market under the reserved symbol "BAPI". Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, Arizona, and Montana. Your state, Coming Soon!
For more information on this fascinating concept please visit us at www.baristas.tv
Annual Report
Fri, Apr 26, 2013 05:22 - Baristas Coffee Company Inc. (BCCI: OTC Link) released their Annual Report. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=103188.
Baristas Submits Formal Application for NASDAQ Listing.
SEATTLE, March 15, 2013 /PRNewswire/ -- Baristas Coffee Company Inc. (OTCPK:BCCI), a fast growing U.S. based beverage and branded products company, has today announced that it has submitted its application for submission on the NASDAQ stock market. Last week it had received the symbol BAPI to be reserved for trading once the Company completes the application process and comment periods. Baristas will continue to trade under the symbol OTCPK:BCCI until such time as it begins to trade on the NASDAQ Capital Markets.
Baristas will continue to submit additional information and documentation as it is required based on comments from its assigned Listing Analyst and others at NASDAQ who will be assisting in Baristas, assuring that they satisfy all the required qualifications for NASDAQ Capital Markets securities in Rule 4300. Baristas will also need to adhere to the corporate governance standards set by NASDAQ. In addition, Baristas must comply with NASDAQ's requirements relating to audit committees, the director nomination's process, and the compensation of officers, board composition, executive sessions, quorum and code of conduct.
The NASDAQ Capital Market provides companies the required capital in order to grow their business. The NASDAQ Capital Market also provides a listing venue that promises to accommodate the different stages of corporate lives of the companies.
Barry Henthorn CEO commented; "We have now taken another significant step towards Baristas moving from the OTC to the NASDAQ Capital Market. We recognize that there is still a great deal of work that must be completed in order for us to complete the process and that our success is dependent on our ability to complete our goals. As part of the requirement for instance we will be establishing an independent Board of Directors, Audit Committees, and focusing on increasing our shareholders equity. We are fully committed to completing the process, increasing shareholder confidence, providing increased transparency and are looking forward to joining the NASDAQ Capital Markets."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, Arizona, and Montana. Your state, Coming Soon!
For more information on this fascinating concept please visit us at www.baristas.tv.
DHS Holding, Co. Confirms LuckyFoxCasino.com
DHS Holding, Co. (PINKSHEETS: DHSM) has a wholly-owned subsidiary, Lucky Fox Casino, LTD, which operates out of Belize. Lucky Fox Casino, LTD signed a contract with FenServices to have LuckyFoxCasino.com developed and maintained. FenServices licensed software from SoftBet and other vendors that develop online casino gaming software. These vendors are the respective owners of the software that they develop, and through FenServices, Lucky Fox has licensed the use of their software for the LuckyFoxCasino.com website.
In short, DHS Holding, Co. owns LuckyFoxCasino.com through its subsidiary, Lucky Fox Casino, LTD.
About the company
The primary focus of DHS Holding Co. is directed to pursue mergers and acquisitions of companies with potential for growth and success. DHS is aggressively moving to develop and expand on both domestic and international opportunities that include launching an online casino through Lucky Fox Casino, LTD, a wholly-owned subsidiary of DHS Holding, Co. and SalesKing.com.
Source Information
www.dhsholding.com
www.otcmarkets.com/stock/dhsm/quote
Safe Harbor Statement
Doesn't matter. We made money!!
Cord Blood America Announces 2013 First Quarter Financial Results
LAS VEGAS, May 15, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended March 31, 2013.
First Quarter 2013 Highlights From Continuing Operations
Recurring revenues increased approximately 7% for the three months ended March 31, 2013 to $740,124.
Cash provided by operations totaled $128,970 in the first quarter. This represents 68% of the total full year cash generated in 2012 of $190,323.
EBITDA for the quarter increased 587% to $99,985 from $14,542 in the year ago period.
SG&A decreased 11% to $1.11 million from $1.24 million in the year ago period.
Our cash balance increased 40% to $369,186 compared to the same period a year ago.
Joseph Vicente, President of Cord Blood America, Inc. commented "During the quarter, Biocordcell Argentina (Bio), made investments in lab related processes, causing increased costs which we expect to be primarily one-time charges. The Company believes these investments will help support future growth. We remain focused on reducing our corporate costs, which were down 11%, despite the increased costs from Bio in the first quarter. We also remain committed to ensuring that incremental revenue growth meets a corresponding increase in profitability, as the Company will not add to its debt under the current conditions. We remain bullish on the industry and our prospects for future growth."
For the three months ended March 31, 2013, total revenue increased to approximately $1.45 million from $1.43 million compared to the year ago period. Recurring revenues increased approximately 7% while tissue related sales increased at 31%, offset by an 11% decrease in processing fees.
Administrative and selling expenses for the three months ended March 31, 2013 were $1.11 million as compared to $1.24 million for the comparative period of 2012, representing an 11% decrease. These expenses are primarily related to marketing/advertising, professional services, allocated facility related expenses and wages for personnel. Generally, each functional unit within administrative and selling expenses has reduced expenses from the prior comparative period. The Company continues to evaluate its expenses and their relationship to revenues for alignment.
For the period ending March 31, 2013, the company had $0.39 million in cash, an increase of 40% from the prior comparative period total of $0.28 million. The Company currently collects cash receipts from operations through CBAI and its subsidiary, Bio-cells. Cash flows from operations are currently sufficient to fund operations. During the three month period ended March 31, 2013 there was no increase in notes payable for purposes of working capital or investment in affiliate companies. Net cash provided by operating activities for the three month period ending March 31, 2013 was $0.13 million, versus a use of $1.00 million cash from the prior comparative period of 2012, an improvement of $0.23 million.
Mr. Vicente concluded, "We have now completed four consecutive quarters operating off cash generated from our operations without any additional outside investment. To add additional clarity on the improvements we have made within the Company, in the first quarter of the prior year we took $458,664 in outside investment capital to fund operations compared to our current quarter, in which we did not take any investment capital, and instead generated $128,970 from operating activities."
About Cord Blood America
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.
Baristas Ice Cream arrives in C-Town and Bravo stores in New York
SEATTLE, April 30, 2013 /PRNewswire/ -- Baristas Coffee Company Inc. (OTCPK: BCCI) or ("the Company"), a fast growing U.S. based beverage and branded products company, has today announced that C-Town and Bravo Supermarkets are now carrying Baristas indulgent collection of coffee ice creams ("Barista Coffee Creations"), featuring classic flavors like "Caramel Cappuccino" and new specialty creations like "Coconut Cafe Latte."
The products are now available in approximately 40 C-Town and Bravo Supermarkets throughout the New York metropolitan region. The first run includes four packs of ice cream bars in both "Caramel Cappuccino" a caramel swirled coffee ice cream enrobed in dark chocolate and "Coconut Cafe Latte" a coconut swirled coffee ice cream enrobed in dark chocolate.
Barry Henthorn CEO commented; "The addition of C-Town and Bravo chain of supermarkets carrying our premium ice cream products continues to expand the footprint, exposure, and accessibility of this newly created product. We are especially encouraged that the "Baristas Coffee Creations" initial product, created from the ground up has had such a strong acceptance from such long standing staples in the supermarket world as C-Town and Bravo."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, and Montana. Your state, Coming Soon!
About C-Town/Bravo: C-Town Supermarkets is a chain of independently owned and operated supermarkets operating in the northeastern United States. C-Town was founded in 1975 with the goal of employing economies of scale to allow its small member stores to pool their purchasing and advertising power. C-Town operates approximately 200 stores in Connecticut, Massachusetts, New Jersey, New York, and Pennsylvania. C-Town is the fifth-largest food retailer in the New York City metropolitan area. C-Town is supplied by Krasdale Foods; many products sold in C-Town stores are labeled "Krasdale Foods." (Krasdale also is a supplier for the smaller Bravo supermarket chain.)
For more information on this fascinating concept please visit us at www.baristas.tv
This is more exciting than the rest of my portfolio, mostly blue chip stocks. DHSM $$$$$$
I just had my order filled again. Loaded and ready to go. DHSM$$$$$$
:) Thank you
I just flipped my 7s. Over 1,000,000. Going back in for more. DHSM is $$$$$$$
DHSM is on fire$$$$$$
Lets all make some money! DHSM $$$$$$$$$$
Stock market is like gambling at a casino... Only DHSM is a casino! $$$$$$$
Stock market is like gambling at a casino... Only DHSM is a casino! $$$$$$$
Cann anyone say cha- Ching!,,,$$$$ DHSM!!!!!
:) DHS Holding, Co. Confirms LuckyFoxCasino.com
DHS Holding, Co. (PINKSHEETS: DHSM) has a wholly-owned subsidiary, Lucky Fox Casino, LTD, which operates out of Belize. Lucky Fox Casino, LTD signed a contract with FenServices to have LuckyFoxCasino.com developed and maintained. FenServices licensed software from SoftBet and other vendors that develop online casino gaming software. These vendors are the respective owners of the software that they develop, and through FenServices, Lucky Fox has licensed the use of their software for the LuckyFoxCasino.com website.
In short, DHS Holding, Co. owns LuckyFoxCasino.com through its subsidiary, Lucky Fox Casino, LTD.
About the company
The primary focus of DHS Holding Co. is directed to pursue mergers and acquisitions of companies with potential for growth and success. DHS is aggressively moving to develop and expand on both domestic and international opportunities that include launching an online casino through Lucky Fox Casino, LTD, a wholly-owned subsidiary of DHS Holding, Co. and SalesKing.com.
Source Information
www.dhsholding.com
www.otcmarkets.com/stock/dhsm/quote
Safe Harbor Statement
DHSM $$$$$$$$$
DHSM $$$$$$$$
Cord Blood America Announces 2013 First Quarter Financial Results
LAS VEGAS, May 15, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended March 31, 2013.
First Quarter 2013 Highlights From Continuing Operations
Recurring revenues increased approximately 7% for the three months ended March 31, 2013 to $740,124.
Cash provided by operations totaled $128,970 in the first quarter. This represents 68% of the total full year cash generated in 2012 of $190,323.
EBITDA for the quarter increased 587% to $99,985 from $14,542 in the year ago period.
SG&A decreased 11% to $1.11 million from $1.24 million in the year ago period.
Our cash balance increased 40% to $369,186 compared to the same period a year ago.
Joseph Vicente, President of Cord Blood America, Inc. commented "During the quarter, Biocordcell Argentina (Bio), made investments in lab related processes, causing increased costs which we expect to be primarily one-time charges. The Company believes these investments will help support future growth. We remain focused on reducing our corporate costs, which were down 11%, despite the increased costs from Bio in the first quarter. We also remain committed to ensuring that incremental revenue growth meets a corresponding increase in profitability, as the Company will not add to its debt under the current conditions. We remain bullish on the industry and our prospects for future growth."
For the three months ended March 31, 2013, total revenue increased to approximately $1.45 million from $1.43 million compared to the year ago period. Recurring revenues increased approximately 7% while tissue related sales increased at 31%, offset by an 11% decrease in processing fees.
Administrative and selling expenses for the three months ended March 31, 2013 were $1.11 million as compared to $1.24 million for the comparative period of 2012, representing an 11% decrease. These expenses are primarily related to marketing/advertising, professional services, allocated facility related expenses and wages for personnel. Generally, each functional unit within administrative and selling expenses has reduced expenses from the prior comparative period. The Company continues to evaluate its expenses and their relationship to revenues for alignment.
For the period ending March 31, 2013, the company had $0.39 million in cash, an increase of 40% from the prior comparative period total of $0.28 million. The Company currently collects cash receipts from operations through CBAI and its subsidiary, Bio-cells. Cash flows from operations are currently sufficient to fund operations. During the three month period ended March 31, 2013 there was no increase in notes payable for purposes of working capital or investment in affiliate companies. Net cash provided by operating activities for the three month period ending March 31, 2013 was $0.13 million, versus a use of $1.00 million cash from the prior comparative period of 2012, an improvement of $0.23 million.
Mr. Vicente concluded, "We have now completed four consecutive quarters operating off cash generated from our operations without any additional outside investment. To add additional clarity on the improvements we have made within the Company, in the first quarter of the prior year we took $458,664 in outside investment capital to fund operations compared to our current quarter, in which we did not take any investment capital, and instead generated $128,970 from operating activities."
About Cord Blood America
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.
Annual Report
Fri, Apr 26, 2013 05:22 - Baristas Coffee Company Inc. (BCCI: OTC Link) released their Annual Report. To read the complete report, please visit: https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=103188.
Baristas Ice Cream arrives in C-Town and Bravo stores in New York
SEATTLE, April 30, 2013 /PRNewswire/ -- Baristas Coffee Company Inc. (OTCPK: BCCI) or ("the Company"), a fast growing U.S. based beverage and branded products company, has today announced that C-Town and Bravo Supermarkets are now carrying Baristas indulgent collection of coffee ice creams ("Barista Coffee Creations"), featuring classic flavors like "Caramel Cappuccino" and new specialty creations like "Coconut Cafe Latte."
The products are now available in approximately 40 C-Town and Bravo Supermarkets throughout the New York metropolitan region. The first run includes four packs of ice cream bars in both "Caramel Cappuccino" a caramel swirled coffee ice cream enrobed in dark chocolate and "Coconut Cafe Latte" a coconut swirled coffee ice cream enrobed in dark chocolate.
Barry Henthorn CEO commented; "The addition of C-Town and Bravo chain of supermarkets carrying our premium ice cream products continues to expand the footprint, exposure, and accessibility of this newly created product. We are especially encouraged that the "Baristas Coffee Creations" initial product, created from the ground up has had such a strong acceptance from such long standing staples in the supermarket world as C-Town and Bravo."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, and Montana. Your state, Coming Soon!
About C-Town/Bravo: C-Town Supermarkets is a chain of independently owned and operated supermarkets operating in the northeastern United States. C-Town was founded in 1975 with the goal of employing economies of scale to allow its small member stores to pool their purchasing and advertising power. C-Town operates approximately 200 stores in Connecticut, Massachusetts, New Jersey, New York, and Pennsylvania. C-Town is the fifth-largest food retailer in the New York City metropolitan area. C-Town is supplied by Krasdale Foods; many products sold in C-Town stores are labeled "Krasdale Foods." (Krasdale also is a supplier for the smaller Bravo supermarket chain.)
For more information on this fascinating concept please visit us at www.baristas.tv
The more they try, the more I buy CBAI $$$$$$$
Financials are excellent:Cord Blood America Announces 2013 First Quarter Financial Results
LAS VEGAS, May 15, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended March 31, 2013.
First Quarter 2013 Highlights From Continuing Operations
Recurring revenues increased approximately 7% for the three months ended March 31, 2013 to $740,124.
Cash provided by operations totaled $128,970 in the first quarter. This represents 68% of the total full year cash generated in 2012 of $190,323.
EBITDA for the quarter increased 587% to $99,985 from $14,542 in the year ago period.
SG&A decreased 11% to $1.11 million from $1.24 million in the year ago period.
Our cash balance increased 40% to $369,186 compared to the same period a year ago.
Joseph Vicente, President of Cord Blood America, Inc. commented "During the quarter, Biocordcell Argentina (Bio), made investments in lab related processes, causing increased costs which we expect to be primarily one-time charges. The Company believes these investments will help support future growth. We remain focused on reducing our corporate costs, which were down 11%, despite the increased costs from Bio in the first quarter. We also remain committed to ensuring that incremental revenue growth meets a corresponding increase in profitability, as the Company will not add to its debt under the current conditions. We remain bullish on the industry and our prospects for future growth."
For the three months ended March 31, 2013, total revenue increased to approximately $1.45 million from $1.43 million compared to the year ago period. Recurring revenues increased approximately 7% while tissue related sales increased at 31%, offset by an 11% decrease in processing fees.
Administrative and selling expenses for the three months ended March 31, 2013 were $1.11 million as compared to $1.24 million for the comparative period of 2012, representing an 11% decrease. These expenses are primarily related to marketing/advertising, professional services, allocated facility related expenses and wages for personnel. Generally, each functional unit within administrative and selling expenses has reduced expenses from the prior comparative period. The Company continues to evaluate its expenses and their relationship to revenues for alignment.
For the period ending March 31, 2013, the company had $0.39 million in cash, an increase of 40% from the prior comparative period total of $0.28 million. The Company currently collects cash receipts from operations through CBAI and its subsidiary, Bio-cells. Cash flows from operations are currently sufficient to fund operations. During the three month period ended March 31, 2013 there was no increase in notes payable for purposes of working capital or investment in affiliate companies. Net cash provided by operating activities for the three month period ending March 31, 2013 was $0.13 million, versus a use of $1.00 million cash from the prior comparative period of 2012, an improvement of $0.23 million.
Mr. Vicente concluded, "We have now completed four consecutive quarters operating off cash generated from our operations without any additional outside investment. To add additional clarity on the improvements we have made within the Company, in the first quarter of the prior year we took $458,664 in outside investment capital to fund operations compared to our current quarter, in which we did not take any investment capital, and instead generated $128,970 from operating activities."
About Cord Blood America
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.
"The Cannabis Connection," Virogen's New Business Unit, Finds Enthusiastic Response to Growth-Through-Acquisition Model from ...
SAN GERONIMO, Calif., May 8, 2013 /PRNewswire/ -- Virogen Inc. (OTC:VRNI), a holding company that owns Tiger Team Technologies and The Cannabis Connection, today advised of its progress following recent announcements concerning its new business unit, The Cannabis Connection, a company initiative designed to capture a portion of the $15-20 billion legal marijuana market.
"Since we announced The Cannabis Connection initiative last week, we have reached out to dispensaries that we view as potential acquisition candidates and have been met with an extremely enthusiastic response," said Paul Hogan, President of VRNI. Mr. Hogan continued, "there are many, many exciting dispensary acquisition opportunities that do not require significant capital investments, but which offer us a seamless entry into an established, expanding market. After completing an acquisition, we intend to 'rebrand' the dispensary with our boutique concept that emphasizes gracious and discrete client services in luxurious surroundings."
VRNI also announced that it has begun discussions with several potential acquisition targets, though these discussions remain preliminary in nature.
In regard to the previously announced cancellation and anticipated cancellations of large blocks of VRNI common stock, the company confirmed the earlier announced cancellation of 1 billion shares, as well as its continuing efforts to complete the cancellation of an additional 5 billion shares. The company stated that it expects to complete the cancellation of the additional 5 billion shares by the end of the second quarter of 2013. Updates to the company's OTC Marketplace information will be completed in the near future.
About Virogen, Inc.
In addition to developing its recently announced business unit, The Cannabis Connection, Virogen, Inc. is a technology holding company. The company's wholly owned subsidiary, Tiger Team Technologies "T3," has developed a unique suite of copyrighted tools to address the network and database security needs of enterprise level companies and corporations. T3's risk management offering provides an unprecedented level of security and liability protection, positioning it as one of the only companies with a comprehensive solution to data security breaches for its clients. T3's primary markets include medical service providers, financial services firms, brokerages and currency transaction platforms, consumer credit card companies, banking entities, retailers, defense and government related operations.
News today! Go CBAI!$$$$$ Cord Blood America Announces 2013 First Quarter Financial Results
LAS VEGAS, May 15, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the quarter ended March 31, 2013.
First Quarter 2013 Highlights From Continuing Operations
Recurring revenues increased approximately 7% for the three months ended March 31, 2013 to $740,124.
Cash provided by operations totaled $128,970 in the first quarter. This represents 68% of the total full year cash generated in 2012 of $190,323.
EBITDA for the quarter increased 587% to $99,985 from $14,542 in the year ago period.
SG&A decreased 11% to $1.11 million from $1.24 million in the year ago period.
Our cash balance increased 40% to $369,186 compared to the same period a year ago.
Joseph Vicente, President of Cord Blood America, Inc. commented "During the quarter, Biocordcell Argentina (Bio), made investments in lab related processes, causing increased costs which we expect to be primarily one-time charges. The Company believes these investments will help support future growth. We remain focused on reducing our corporate costs, which were down 11%, despite the increased costs from Bio in the first quarter. We also remain committed to ensuring that incremental revenue growth meets a corresponding increase in profitability, as the Company will not add to its debt under the current conditions. We remain bullish on the industry and our prospects for future growth."
For the three months ended March 31, 2013, total revenue increased to approximately $1.45 million from $1.43 million compared to the year ago period. Recurring revenues increased approximately 7% while tissue related sales increased at 31%, offset by an 11% decrease in processing fees.
Administrative and selling expenses for the three months ended March 31, 2013 were $1.11 million as compared to $1.24 million for the comparative period of 2012, representing an 11% decrease. These expenses are primarily related to marketing/advertising, professional services, allocated facility related expenses and wages for personnel. Generally, each functional unit within administrative and selling expenses has reduced expenses from the prior comparative period. The Company continues to evaluate its expenses and their relationship to revenues for alignment.
For the period ending March 31, 2013, the company had $0.39 million in cash, an increase of 40% from the prior comparative period total of $0.28 million. The Company currently collects cash receipts from operations through CBAI and its subsidiary, Bio-cells. Cash flows from operations are currently sufficient to fund operations. During the three month period ended March 31, 2013 there was no increase in notes payable for purposes of working capital or investment in affiliate companies. Net cash provided by operating activities for the three month period ending March 31, 2013 was $0.13 million, versus a use of $1.00 million cash from the prior comparative period of 2012, an improvement of $0.23 million.
Mr. Vicente concluded, "We have now completed four consecutive quarters operating off cash generated from our operations without any additional outside investment. To add additional clarity on the improvements we have made within the Company, in the first quarter of the prior year we took $458,664 in outside investment capital to fund operations compared to our current quarter, in which we did not take any investment capital, and instead generated $128,970 from operating activities."
About Cord Blood America
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.
Time to re-buy CBAi $$$$$$
CBAI...someone got the price they wanted for1,200,000 shares. :)
For new members of the board: Cord Blood America Announces 2012 Financial Results
LAS VEGAS, April 1, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the year ended December 31, 2012.
Full Year Ended December 31, 2012 Highlights
Revenue increased 18% to a record $6.0 million from $5.1 million in the year ago period.
Gross Profit increased 20% to $4.2 million from $3.5 million in the year ago period.
SG&A decreased 17% or $1.1 million to $5.6 million in 2012 from $6.7 million in 2011.
Total assets exceeded total liabilities by $0.52 million, a net change of $1.4 million from the prior year of 2011 where the liabilities outpaced company assets.
Net cash balance increased over 116% to $393,832 from the year ago period.
Positive cash flow from operations of $0.19 million, an improvement of 117% compared to the year ago period.
Joseph Vicente, President of Cord Blood America, Inc. commented "After taking over as CEO in May of 2012, our team has made transformational changes to our business model as highlighted in the bullets above. At the same time we recognize we are at an inflection point for the company where incremental revenue growth will drive significantly higher operating profit for the company, highlighting the leverage within our model. Our combined US and South American operating divisions offer the best of both worlds, a high growth engine in Argentina which grew revenue by 35% for the year is providing the annuity streams of tomorrow, combined with our US operations which are growing at a steady rate of 10% while already achieving the scale to generate consistent recurring cash flow that covers the operation's fixed cost, demonstrating further the power of building a sizable customer base."
The Company's cash position continued to improve throughout 2012. The Company increased its cash from operations by $1.71 million from the comparative period of 2011. The impact of this is greatly heightened when one considers the Company's accounts payable balance decreased 37% or $327,000 from 2011 to 2012. "We have been steadfast that the Company needs to operate off its own cash. We continue to do so as evidenced by: our improving cash position; our consistent payment to vendors; and the fact that we did not take any outside investment capital for the last nine months of 2012," commented Mr. Vicente.
Gross profit for the year increased by approximately $0.69 million or 20% to $4.20 million from the prior comparative period. With gross margin as a percentage of revenue up slightly, to 70%, the Company anticipates that through the growth and expansion of its cord blood business in conjunction with continuing efficiencies in its own facilities, direct costs should continue to decrease as a percentage of sales, and gross profits will continue to improve.
Administrative and selling expenses for the year ended December 31, 2012 decreased 17% to $5.63 million as compared to $6.75 million for the comparative period of 2011. The company continues to evaluate each dollar being spent, automating for economies of scale, and understands that incremental revenue growth needs to proportionately drive higher operational profits.
Mr. Vicente concluded, "The last half of 2012 provided measureable improvement across key indicators for revenue, expenses and operating profit. As we progress into 2013, we are focused on expanding our service offerings in the stem cell space, securing additional sales channels to market our services, and ensuring that our sales efforts meet the balance of the fiscal discipline required to continue to build the cash position of the Company, all key contributors to drive the future value for our shareholders."
About Cord Blood America
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.
BCCI chart looks great.
This news is only 14 days old. for new members of the board: Baristas Ice Cream arrives in C-Town and Bravo stores in New York
SEATTLE, April 30, 2013 /PRNewswire/ -- Baristas Coffee Company Inc. (OTCPK: BCCI) or ("the Company"), a fast growing U.S. based beverage and branded products company, has today announced that C-Town and Bravo Supermarkets are now carrying Baristas indulgent collection of coffee ice creams ("Barista Coffee Creations"), featuring classic flavors like "Caramel Cappuccino" and new specialty creations like "Coconut Cafe Latte."
The products are now available in approximately 40 C-Town and Bravo Supermarkets throughout the New York metropolitan region. The first run includes four packs of ice cream bars in both "Caramel Cappuccino" a caramel swirled coffee ice cream enrobed in dark chocolate and "Coconut Cafe Latte" a coconut swirled coffee ice cream enrobed in dark chocolate.
Barry Henthorn CEO commented; "The addition of C-Town and Bravo chain of supermarkets carrying our premium ice cream products continues to expand the footprint, exposure, and accessibility of this newly created product. We are especially encouraged that the "Baristas Coffee Creations" initial product, created from the ground up has had such a strong acceptance from such long standing staples in the supermarket world as C-Town and Bravo."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, and Montana. Your state, Coming Soon!
About C-Town/Bravo: C-Town Supermarkets is a chain of independently owned and operated supermarkets operating in the northeastern United States. C-Town was founded in 1975 with the goal of employing economies of scale to allow its small member stores to pool their purchasing and advertising power. C-Town operates approximately 200 stores in Connecticut, Massachusetts, New Jersey, New York, and Pennsylvania. C-Town is the fifth-largest food retailer in the New York City metropolitan area. C-Town is supplied by Krasdale Foods; many products sold in C-Town stores are labeled "Krasdale Foods." (Krasdale also is a supplier for the smaller Bravo supermarket chain.)
For more information on this fascinating concept please visit us at www.baristas.tv
Contact:
Barry Henthorn
barry@baristas.tv
(206) 579-0222
It's for new members of the board.
Cord Blood America Announces 2012 Financial Results
LAS VEGAS, April 1, 2013 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced financial results for the year ended December 31, 2012.
Full Year Ended December 31, 2012 Highlights
Revenue increased 18% to a record $6.0 million from $5.1 million in the year ago period.
Gross Profit increased 20% to $4.2 million from $3.5 million in the year ago period.
SG&A decreased 17% or $1.1 million to $5.6 million in 2012 from $6.7 million in 2011.
Total assets exceeded total liabilities by $0.52 million, a net change of $1.4 million from the prior year of 2011 where the liabilities outpaced company assets.
Net cash balance increased over 116% to $393,832 from the year ago period.
Positive cash flow from operations of $0.19 million, an improvement of 117% compared to the year ago period.
Joseph Vicente, President of Cord Blood America, Inc. commented "After taking over as CEO in May of 2012, our team has made transformational changes to our business model as highlighted in the bullets above. At the same time we recognize we are at an inflection point for the company where incremental revenue growth will drive significantly higher operating profit for the company, highlighting the leverage within our model. Our combined US and South American operating divisions offer the best of both worlds, a high growth engine in Argentina which grew revenue by 35% for the year is providing the annuity streams of tomorrow, combined with our US operations which are growing at a steady rate of 10% while already achieving the scale to generate consistent recurring cash flow that covers the operation's fixed cost, demonstrating further the power of building a sizable customer base."
The Company's cash position continued to improve throughout 2012. The Company increased its cash from operations by $1.71 million from the comparative period of 2011. The impact of this is greatly heightened when one considers the Company's accounts payable balance decreased 37% or $327,000 from 2011 to 2012. "We have been steadfast that the Company needs to operate off its own cash. We continue to do so as evidenced by: our improving cash position; our consistent payment to vendors; and the fact that we did not take any outside investment capital for the last nine months of 2012," commented Mr. Vicente.
Gross profit for the year increased by approximately $0.69 million or 20% to $4.20 million from the prior comparative period. With gross margin as a percentage of revenue up slightly, to 70%, the Company anticipates that through the growth and expansion of its cord blood business in conjunction with continuing efficiencies in its own facilities, direct costs should continue to decrease as a percentage of sales, and gross profits will continue to improve.
Administrative and selling expenses for the year ended December 31, 2012 decreased 17% to $5.63 million as compared to $6.75 million for the comparative period of 2011. The company continues to evaluate each dollar being spent, automating for economies of scale, and understands that incremental revenue growth needs to proportionately drive higher operational profits.
Mr. Vicente concluded, "The last half of 2012 provided measureable improvement across key indicators for revenue, expenses and operating profit. As we progress into 2013, we are focused on expanding our service offerings in the stem cell space, securing additional sales channels to market our services, and ensuring that our sales efforts meet the balance of the fiscal discipline required to continue to build the cash position of the Company, all key contributors to drive the future value for our shareholders."
About Cord Blood America
Cord Blood America, Inc. is the parent company of CorCell, Companies, Inc. which, along with Cord Blood America, Inc., facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. and CorCell Companies, Inc., visit our websites: http://www.cordblood-america.com/ for investor information and http://www.corcell.com/ for customer information.
CBAI $$$$$$$
For more information on this fascinating concept please visit us at www.baristas.tv
Baristas Files Franchise Documents in 26 Additional States meeting all requirements in over 50% of the nation
SEATTLE, April 16, 2013 /PRNewswire/ -- Baristas Coffee Company Inc. (OTC PINK: BCCI), a fast growing U.S. based beverage and branded products company, today announced that it has filed its Franchise Disclosure Documents with all of the following states: Alabama, Alaska, Arkansas, Colorado, Delaware, Georgia, Idaho, Iowa, Kansas, Louisiana, Massachusetts, Missouri, Mississippi, Montana, Nevada, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, Vermont, West Virginia, Washington DC, and Wyoming,
This filing is subsequent to the filing to become registered in Baristas' home state of Washington, as well as additional registration states, New York and California.
Newly appointed Director of Store and Brand Development, Mike Reynolds, stated: "We have now completed the filing process and are now fully compliant to sell franchises in over 50% of the country. We will now roll out our franchising expansion with committed development partners. We will continue to register in other states that we have received strong interest in so that we may also pursue those regions for franchising as well. Baristas offers a very compelling business model and provides the best opportunity in franchising that I have seen in my career and is clearly the best in its sector."
Barry Henthorn CEO commented; "We now can answer the pent up demand for our exciting franchise concept with full confidence that we have met every requirement. This accomplishment has been the result of a committed effort to comply with the differing regulations of multiple states to insure that we comply with all regulations. Franchising is an important aspect of the expansion of the Baristas brand and will also help reduce our cost of goods sold widening our profit margins."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, currently trades under the symbol (OTC PINK: BCCI) has recently made a formal application to the NASDAQ Capital Market under the reserved symbol "BAPI". Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found in six greater Seattle area locations as well as in Texas, Florida, Arizona, and Montana. Your state, Coming Soon!
For more information on this fascinating concept please visit us at www.baristas.tv
Contact:
Barry Henthorn
barry@baristas.tv
(206) 579-0222
BCCI Ice Cream Is Now Available @ Food Emporium Supermarkets in NY